Literature DB >> 2557152

Beta-adrenergic receptors in congestive heart failure: present knowledge and future directions.

A S Maisel1, M C Michel.   

Abstract

In recent years substantial information has become available on the function and regulation of beta-adrenergic receptors in experimental model systems and in the human heart. Beta-Adrenergic receptors mediate the positive inotropic and chronotropic effects of the sympathetic neurotransmitter norepinephrine in the heart. They can be altered in various disease states including congestive heart failure. In order to enhance understanding of beta-adrenergic receptor regulation in heart failure, we here review the present knowledge and the open question in three areas: (1) the differential role of beta 1- and beta 2-adrenergic receptors: (2) regulation of the number of cardiac beta-adrenergic receptors by drugs and disease states: and (3) regulation of the responsiveness of cardiac beta-adrenergic receptors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2557152     DOI: 10.1159/000174517

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  4 in total

1.  Myocardial beta-adrenoceptor density and the distribution of beta 1- and beta 2-adrenoceptor subpopulations in children with congenital heart disease.

Authors:  R Kozlik; H H Kramer; H Wicht; A Krian; J Ostermeyer; D Reinhardt
Journal:  Eur J Pediatr       Date:  1991-04       Impact factor: 3.183

2.  Beta-adrenoceptor density on mononuclear leukocytes and right atrial myocardium in infants and children with congenital heart disease.

Authors:  R Kozlik; H H Kramer; H Wicht; W Bircks; D Reinhardt
Journal:  Klin Wochenschr       Date:  1991-12-11

Review 3.  The bidirectional interaction between the sympathetic nervous system and immune mechanisms in the pathogenesis of hypertension.

Authors:  Revathy Carnagarin; Vance Matthews; Maria T K Zaldivia; Karlheinz Peter; Markus P Schlaich
Journal:  Br J Pharmacol       Date:  2018-09-25       Impact factor: 8.739

4.  Redox-regulated suppression of splenic T-lymphocyte activation in a model of sympathoexcitation.

Authors:  Adam J Case; Matthew C Zimmerman
Journal:  Hypertension       Date:  2015-02-17       Impact factor: 10.190

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.